Seodaemun-gu, South Korea

Cheol Won Park


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Seodaemun-gu, KR (2002)
  • Seoul, KR (2005)
  • Taejeon, KR (2006)

Company Filing History:


Years Active: 2002-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Cheol Won Park: Innovator in Thrombin Inhibitor Development**

Introduction

Cheol Won Park is a prominent inventor based in Seodaemun-gu, South Korea. He has made significant contributions to the field of pharmaceutical development, particularly in creating innovative compounds for treating various medical conditions. With a total of three patents to his name, his work showcases the intersection of chemistry and pharmacology.

Latest Patents

One of his latest innovations is the patent for a **Process for preparing 5-aminomethyl-2-thiophenecarbonitrile HCl by one-pot reaction**. This invention describes a novel and efficient method for synthesizing a compound that serves as an important intermediate for oral thrombin inhibitors, achieving high yields through a one-pot reaction method.

Another key patent involves **Piperidine and azetidine thrombin inhibitors**. This invention relates to a class of compounds that function as thrombin inhibitors and can be utilized as anticoagulants. These innovative compounds, along with their pharmaceutically acceptable salts, have the potential to greatly enhance treatment options for patients with thrombotic conditions.

Career Highlights

Cheol Won Park is currently affiliated with LG Life Sciences Limited, where he continues to advance research in pharmaceutical sciences. His role at this leading company reflects his dedication to developing new therapeutic solutions that address critical health issues.

Collaborations

Throughout his career, Cheol has collaborated with talented individuals such as Koo Lee and Won Hyuk Jung. These partnerships with fellow researchers enable the exchange of ideas and contribute to the innovative environment at LG Life Sciences.

Conclusion

Cheol Won Park's contributions to the field of pharmaceutical innovation demonstrate the importance of research and dedication in creating effective medical treatments. With his recent patents, he is making a tangible impact in the area of thrombin inhibitors, aiming to improve patient outcomes through science-driven solutions. His work serves as an inspiration for aspiring inventors and emphasizes the vital role of collaboration in scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…